Antibody neutralizers of human granulocyte macrophage colony stimulating factor
AssigneeAmgen Research (Munich) GmbH
InventorsTobias Raum, Julia Hepp, Eva Vieser, Silke Petsch, Steven Zeman, Andreas Wolf, Sandra Bruckmaier
Life of this patent
Estimating the term…
Abstract
The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
Claims20
A human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF, comprising in its light chain variable region a CDR1 comprising an amino acid sequence as set out in SEQ ID NO:
- 16, a CDR2 comprising an amino acid sequence as set out in SEQ ID) NO:
- 17 and a CDR3comprising an amino acid sequence as set out in SEQ ID NO:
- 18;
- and comprising in its heavy chain variable region a CDR1 comprising an amino acid sequence as set out in SEQ ID NO:
- 14, a CDR2 comprising an amino acid sequence as set out in SEQ ID NO:
- 15 and a CDR3 comprising an amino acid sequence as set out in any of SEQ ID NOs:
- 1-13 or 56.
An immunoglobulin G antibody which binds to human GM-CSF, comprising in its light chain variable region a CDR1 comprising an amino acid sequence as set out in SEQ ID NO:
- 16, a CDR2 comprising an amino acid sequence as set out in SEQ ID NO:
- 17and a CDR3 comprising an amino acid sequence as set out in SEQ ID NO:
- 18;
- and
- comprising in its heavy chain variable region a CDR1 comprising an amino acid sequence as set out in SEQ ID NO:
- 14, a CDR2 comprising an amino acid sequence as set out in SEQ ID NO:
- 15 and a CDR3 comprising an amino acid sequence as set out in SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.